$ADRO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CHINOOK THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CHINOOK THERAPEUTICS, INC.. Get notifications about new insider transactions in CHINOOK THERAPEUTICS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Option Exercise | M | 0.35 | 20,000 | 7,000 | 423,358 | |
Jun 15 2021 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | M | 0.35 | 20,000 | 7,000 | 97,837 | 77.8 K to 97.8 K (+25.69 %) |
Jun 08 2021 | ADRO | CHINOOK THERAPEUTI ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 16.81 | 5,948 | 99,986 | 5,948 | |
Jun 07 2021 | ADRO | CHINOOK THERAPEUTI ... | Thomas Dolca | Director | Option Exercise | A | 16.81 | 5,948 | 99,986 | 5,948 | |
Jun 07 2021 | ADRO | CHINOOK THERAPEUTI ... | Thomas Dolca | Director | Option Exercise | A | 16.81 | 5,948 | 99,986 | 5,948 | |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | King Andrew James | Head of Renal Disco ... | Option Exercise | A | 0.00 | 20,406 | 0 | 20,406 | |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | King Andrew James | Head of Renal Disco ... | Option Exercise | A | 15.14 | 60,000 | 908,400 | 60,000 | |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | Glicklich Alan | Chief Medical Offic ... | Option Exercise | A | 0.00 | 17,005 | 0 | 17,005 | |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | Glicklich Alan | Chief Medical Offic ... | Option Exercise | A | 15.14 | 50,000 | 757,000 | 50,000 | |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | Frohlich Tom | Chief Business Offi ... | Option Exercise | A | 0.00 | 20,406 | 0 | 20,406 | |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | Frohlich Tom | Chief Business Offi ... | Option Exercise | A | 15.14 | 60,000 | 908,400 | 60,000 | |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.00 | 60,743 | 0 | 60,743 | |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 15.14 | 178,600 | 2,704,004 | 178,600 | |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 0.00 | 7,304 | 0 | 7,304 | |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 15.14 | 21,501 | 325,525 | 21,501 | |
Dec 22 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Option Exercise | M | 0.35 | 20,000 | 7,000 | 443,358 | |
Dec 22 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | M | 0.35 | 20,000 | 7,000 | 76,837 | 56.8 K to 76.8 K (+35.19 %) |
Dec 18 2020 | ADRO | CHINOOK THERAPEUTI ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 0.00 | 49,243 | 0 | 49,243 | |
Dec 18 2020 | ADRO | CHINOOK THERAPEUTI ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 13.98 | 144,787 | 2,024,122 | 144,787 | |
Dec 10 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.08 | 2,000 | 26,150 | 56,837 | 54.8 K to 56.8 K (+3.65 %) |
Dec 10 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.24 | 2,000 | 26,483 | 54,837 | 52.8 K to 54.8 K (+3.79 %) |
Nov 23 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.67 | 929 | 12,699 | 52,837 | 51.9 K to 52.8 K (+1.79 %) |
Nov 23 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.69 | 571 | 7,817 | 51,908 | 51.3 K to 51.9 K (+1.11 %) |
Nov 23 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.50 | 500 | 6,750 | 51,337 | 50.8 K to 51.3 K (+0.98 %) |
Nov 13 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.75 | 2,500 | 34,375 | 50,837 | 48.3 K to 50.8 K (+5.17 %) |
Nov 13 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.86 | 2,000 | 27,720 | 48,337 | 46.3 K to 48.3 K (+4.32 %) |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Glicklich Alan | Chief Medical Offic ... | Option Exercise | A | 0.00 | 21,311 | 0 | 21,311 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Glicklich Alan | Chief Medical Offic ... | Option Exercise | A | 0.00 | 21,311 | 0 | 21,311 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Glicklich Alan | Chief Medical Offic ... | Option Exercise | A | 14.77 | 62,660 | 925,488 | 62,660 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Glicklich Alan | Chief Medical Offic ... | Option Exercise | A | 14.77 | 62,660 | 925,488 | 62,660 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Glicklich Alan | Chief Medical Offic ... | Option Exercise | A | 0.42 | 242,662 | 101,918 | 242,662 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Glicklich Alan | Chief Medical Offic ... | Option Exercise | A | 0.42 | 242,662 | 101,918 | 242,662 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 14.77 | 23,522 | 347,420 | 23,522 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 14.77 | 23,522 | 347,420 | 23,522 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 3,168,388 | 0 | 3,168,388 | 0 to 3.2 M |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 3,168,388 | 0 | 3,168,388 | 0 to 3.2 M |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Thomas Dolca | Director | Option Exercise | A | 14.77 | 23,522 | 347,420 | 23,522 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Thomas Dolca | Director | Option Exercise | A | 14.77 | 23,522 | 347,420 | 23,522 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 14.77 | 23,522 | 347,420 | 23,522 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 14.77 | 23,522 | 347,420 | 23,522 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Jerel Davis | Director | Option Exercise | A | 14.77 | 23,522 | 347,420 | 23,522 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Jerel Davis | Director | Grant | A | 0.00 | 2,433,099 | 0 | 2,433,099 | 0 to 2.4 M |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Jerel Davis | Director | Option Exercise | A | 14.77 | 23,522 | 347,420 | 23,522 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Jerel Davis | Director | Grant | A | 0.00 | 722,247 | 0 | 722,247 | 0 to 722.2 K |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Jerel Davis | Director | Grant | A | 0.00 | 2,433,099 | 0 | 2,433,099 | 0 to 2.4 M |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Jerel Davis | Director | Grant | A | 0.00 | 4,733,023 | 0 | 4,733,023 | 0 to 4.7 M |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Jerel Davis | Director | Grant | A | 0.00 | 722,247 | 0 | 722,247 | 0 to 722.2 K |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Jerel Davis | Director | Grant | A | 0.00 | 730,470 | 0 | 730,470 | 0 to 730.5 K |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Jerel Davis | Director | Grant | A | 0.00 | 4,733,023 | 0 | 4,733,023 | 0 to 4.7 M |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Jerel Davis | Director | Grant | A | 0.00 | 730,470 | 0 | 730,470 | 0 to 730.5 K |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | King Andrew James | Head of Renal Disco ... | Option Exercise | A | 0.00 | 30,455 | 0 | 30,455 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | King Andrew James | Head of Renal Disco ... | Option Exercise | A | 14.77 | 89,545 | 1,322,580 | 89,545 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | King Andrew James | Head of Renal Disco ... | Option Exercise | A | 0.00 | 30,455 | 0 | 30,455 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | King Andrew James | Head of Renal Disco ... | Option Exercise | A | 0.42 | 73,047 | 30,680 | 73,047 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | King Andrew James | Head of Renal Disco ... | Option Exercise | A | 14.77 | 89,545 | 1,322,580 | 89,545 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | King Andrew James | Head of Renal Disco ... | Option Exercise | A | 0.35 | 73,047 | 25,566 | 73,047 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | King Andrew James | Head of Renal Disco ... | Option Exercise | A | 0.42 | 73,047 | 30,680 | 73,047 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | King Andrew James | Head of Renal Disco ... | Option Exercise | A | 0.35 | 73,047 | 25,566 | 73,047 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Frohlich Tom | Chief Business Offi ... | Option Exercise | A | 0.00 | 40,743 | 0 | 40,743 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Frohlich Tom | Chief Business Offi ... | Option Exercise | A | 14.77 | 119,793 | 1,769,343 | 119,793 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Frohlich Tom | Chief Business Offi ... | Option Exercise | A | 0.00 | 40,743 | 0 | 40,743 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Frohlich Tom | Chief Business Offi ... | Option Exercise | A | 0.42 | 98,847 | 41,516 | 98,847 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Frohlich Tom | Chief Business Offi ... | Option Exercise | A | 14.77 | 119,793 | 1,769,343 | 119,793 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Frohlich Tom | Chief Business Offi ... | Grant | A | 0.00 | 153,398 | 0 | 153,398 | 0 to 153.4 K |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Frohlich Tom | Chief Business Offi ... | Option Exercise | A | 0.42 | 98,847 | 41,516 | 98,847 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | Frohlich Tom | Chief Business Offi ... | Grant | A | 0.00 | 153,398 | 0 | 153,398 | 0 to 153.4 K |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.00 | 92,389 | 0 | 92,389 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.00 | 92,389 | 0 | 92,389 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 14.77 | 271,647 | 4,012,226 | 271,647 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 14.77 | 271,647 | 4,012,226 | 271,647 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.42 | 423,555 | 177,893 | 423,555 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.42 | 423,555 | 177,893 | 423,555 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.35 | 463,358 | 162,175 | 463,358 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.35 | 463,358 | 162,175 | 463,358 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Grant | A | 0.00 | 46,337 | 0 | 46,337 | 0 to 46.3 K |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Grant | A | 0.00 | 46,337 | 0 | 46,337 | 0 to 46.3 K |
Sep 17 2020 | ADRO | ADURO BIOTECH, INC ... | ISAACS STEPHEN T | President and CEO | Sell | S | 2.39 | 32,481 | 77,691 | 279,166 | 311.6 K to 279.2 K (-10.42 %) |
Sep 17 2020 | ADRO | ADURO BIOTECH, INC ... | Templeman Blaine | Chief Legal Officer | Sell | S | 2.39 | 12,369 | 29,585 | 121,916 | 134.3 K to 121.9 K (-9.21 %) |
Sep 17 2020 | ADRO | ADURO BIOTECH, INC ... | Ferber Celeste | SVP, GC and Secreta ... | Sell | S | 2.39 | 2,396 | 5,731 | 38,687 | 41.1 K to 38.7 K (-5.83 %) |
Aug 11 2020 | ADRO | ADURO BIOTECH, INC ... | Nuyten Dimitry SA | Chief Medical Offic ... | Sell | S | 2.55 | 3,538 | 9,036 | 8,462 | 12 K to 8.5 K (-29.48 %) |
Aug 11 2020 | ADRO | ADURO BIOTECH, INC ... | Templeman Blaine | Chief Legal Officer | Sell | S | 2.55 | 7,951 | 20,308 | 134,285 | 142.2 K to 134.3 K (-5.59 %) |
Aug 11 2020 | ADRO | ADURO BIOTECH, INC ... | Ferber Celeste | SVP, GC and Secreta ... | Sell | S | 2.55 | 7,951 | 20,308 | 41,083 | 49 K to 41.1 K (-16.22 %) |
Jun 03 2020 | ADRO | ADURO BIOTECH, INC ... | Kachioff William G | Interim CFO | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jun 03 2020 | ADRO | ADURO BIOTECH, INC ... | Ferber Celeste | SVP, GC and Secreta ... | Grant | A | 0.00 | 22,500 | 0 | 49,034 | 26.5 K to 49 K (+84.80 %) |
Jun 03 2020 | ADRO | ADURO BIOTECH, INC ... | Haghighat Ross | Director | Grant | A | 0.00 | 34,124 | 0 | 121,246 | 87.1 K to 121.2 K (+39.17 %) |
Jun 03 2020 | ADRO | ADURO BIOTECH, INC ... | Nuyten Dimitry SA | Chief Medical Offic ... | Grant | A | 0.00 | 10,000 | 0 | 12,000 | 2 K to 12 K (+500.00 %) |
Jun 03 2020 | ADRO | ADURO BIOTECH, INC ... | Templeman Blaine | Chief Legal Officer | Grant | A | 0.00 | 22,500 | 0 | 142,236 | 119.7 K to 142.2 K (+18.79 %) |
May 28 2020 | ADRO | ADURO BIOTECH, INC ... | Mack David Henry | Director | Option Exercise | A | 3.00 | 30,000 | 90,000 | 30,000 | |
May 28 2020 | ADRO | ADURO BIOTECH, INC ... | KARBE FRANK | Director | Option Exercise | A | 3.00 | 30,000 | 90,000 | 30,000 | |
May 28 2020 | ADRO | ADURO BIOTECH, INC ... | Haghighat Ross | Director | Option Exercise | A | 3.00 | 30,000 | 90,000 | 30,000 | |
May 28 2020 | ADRO | ADURO BIOTECH, INC ... | Greenman William Mariner | Director | Option Exercise | A | 3.00 | 30,000 | 90,000 | 30,000 | |
May 28 2020 | ADRO | ADURO BIOTECH, INC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 3.00 | 30,000 | 90,000 | 30,000 | |
May 28 2020 | ADRO | ADURO BIOTECH, INC ... | OBrien Stephanie Monaghan | Director | Option Exercise | A | 3.00 | 30,000 | 90,000 | 30,000 | |
Mar 20 2020 | ADRO | ADURO BIOTECH, INC ... | Greenman William Mariner | Director | Option Exercise | M | 0.45 | 2,458 | 1,106 | 0 | |
Mar 20 2020 | ADRO | ADURO BIOTECH, INC ... | Greenman William Mariner | Director | Option Exercise | M | 0.45 | 4,566 | 2,055 | 0 | |
Mar 20 2020 | ADRO | ADURO BIOTECH, INC ... | Greenman William Mariner | Director | Option Exercise | M | 0.45 | 12,811 | 5,765 | 0 | |
Mar 20 2020 | ADRO | ADURO BIOTECH, INC ... | Greenman William Mariner | Director | Buy | M | 0.45 | 19,835 | 8,926 | 19,835 | 0 to 19.8 K |
Mar 20 2020 | ADRO | ADURO BIOTECH, INC ... | ISAACS STEPHEN T | President and CEO | Option Exercise | M | 0.45 | 21,618 | 9,728 | 0 | |
Mar 20 2020 | ADRO | ADURO BIOTECH, INC ... | ISAACS STEPHEN T | President and CEO | Sell | M | 0.45 | 21,618 | 9,728 | 311,647 | 333.3 K to 311.6 K (-6.49 %) |
Feb 26 2020 | ADRO | ADURO BIOTECH, INC ... | van Elsas Andrea | Chief Scientific Of ... | Sell | S | 3.51 | 6,823 | 23,954 | 438,367 | 445.2 K to 438.4 K (-1.53 %) |
Feb 24 2020 | ADRO | ADURO BIOTECH, INC ... | van Elsas Andrea | Chief Scientific Of ... | Option Exercise | A | 3.65 | 250,000 | 912,500 | 250,000 | |
Feb 24 2020 | ADRO | ADURO BIOTECH, INC ... | van Elsas Andrea | Chief Scientific Of ... | Option Exercise | A | 3.65 | 250,000 | 912,500 | 250,000 | |
Feb 24 2020 | ADRO | ADURO BIOTECH, INC ... | Templeman Blaine | Chief Legal Officer | Option Exercise | A | 3.65 | 250,000 | 912,500 | 250,000 | |
Feb 24 2020 | ADRO | ADURO BIOTECH, INC ... | ISAACS STEPHEN T | President and CEO | Option Exercise | A | 3.65 | 850,000 | 3,102,500 | 850,000 | |
Feb 24 2020 | ADRO | ADURO BIOTECH, INC ... | Nuyten Dimitry SA | Chief Medical Offic ... | Option Exercise | A | 3.65 | 250,000 | 912,500 | 250,000 | |
Feb 24 2020 | ADRO | ADURO BIOTECH, INC ... | Ferber Celeste | SVP, GC and Secreta ... | Option Exercise | A | 3.65 | 250,000 | 912,500 | 250,000 | |
Jan 06 2020 | ADRO | ADURO BIOTECH, INC ... | van Elsas Andrea | Chief Scientific Of ... | Sell | S | 1.19 | 73,311 | 87,108 | 445,190 | 518.5 K to 445.2 K (-14.14 %) |
Dec 16 2019 | ADRO | ADURO BIOTECH, INC ... | Ferber Celeste | SVP, GC and Secreta ... | Sell | S | 1.16 | 408 | 475 | 26,534 | 26.9 K to 26.5 K (-1.51 %) |
Dec 16 2019 | ADRO | ADURO BIOTECH, INC ... | van Elsas Andrea | Chief Scientific Of ... | Sell | S | 1.16 | 2,192 | 2,550 | 518,501 | 520.7 K to 518.5 K (-0.42 %) |
Dec 16 2019 | ADRO | ADURO BIOTECH, INC ... | ISAACS STEPHEN T | President and CEO | Sell | S | 1.16 | 5,897 | 6,860 | 290,029 | 295.9 K to 290 K (-1.99 %) |
Sep 18 2019 | ADRO | ADURO BIOTECH, INC ... | Haghighat Ross | Director | Option Exercise | M | 0.52 | 9,063 | 4,713 | 0 | |
Sep 18 2019 | ADRO | ADURO BIOTECH, INC ... | Haghighat Ross | Director | Option Exercise | M | 0.45 | 2,459 | 1,107 | 0 | |
Sep 18 2019 | ADRO | ADURO BIOTECH, INC ... | Haghighat Ross | Director | Option Exercise | M | 0.45 | 4,566 | 2,055 | 0 | |
Sep 18 2019 | ADRO | ADURO BIOTECH, INC ... | Haghighat Ross | Director | Option Exercise | M | 0.45 | 21,451 | 9,653 | 0 | |
Sep 18 2019 | ADRO | ADURO BIOTECH, INC ... | Haghighat Ross | Director | Option Exercise | M | 1.00 | 18,000 | 18,000 | 0 | |
Sep 18 2019 | ADRO | ADURO BIOTECH, INC ... | Haghighat Ross | Director | Buy | M | 0.52 | 9,063 | 4,713 | 87,122 | 78.1 K to 87.1 K (+11.61 %) |
Sep 18 2019 | ADRO | ADURO BIOTECH, INC ... | Haghighat Ross | Director | Buy | M | 0.45 | 2,459 | 1,107 | 78,059 | 75.6 K to 78.1 K (+3.25 %) |
Sep 18 2019 | ADRO | ADURO BIOTECH, INC ... | Haghighat Ross | Director | Buy | M | 0.45 | 4,566 | 2,055 | 75,600 | 71 K to 75.6 K (+6.43 %) |
Sep 18 2019 | ADRO | ADURO BIOTECH, INC ... | Haghighat Ross | Director | Buy | M | 0.45 | 21,451 | 9,653 | 71,034 | 49.6 K to 71 K (+43.26 %) |
Sep 18 2019 | ADRO | ADURO BIOTECH, INC ... | Haghighat Ross | Director | Buy | M | 1.00 | 18,000 | 18,000 | 49,583 | 31.6 K to 49.6 K (+56.99 %) |
Sep 17 2019 | ADRO | ADURO BIOTECH, INC ... | Ferber Celeste | SVP, GC and Secreta ... | Sell | S | 1.31 | 1,102 | 1,439 | 26,942 | 28 K to 26.9 K (-3.93 %) |
Sep 17 2019 | ADRO | ADURO BIOTECH, INC ... | Ferber Celeste | SVP, GC and Secreta ... | Sell | S | 1.31 | 1,392 | 1,818 | 28,044 | 29.4 K to 28 K (-4.73 %) |
Sep 17 2019 | ADRO | ADURO BIOTECH, INC ... | ISAACS STEPHEN T | President and CEO | Sell | S | 1.31 | 31,098 | 40,608 | 295,926 | 327 K to 295.9 K (-9.51 %) |
Sep 17 2019 | ADRO | ADURO BIOTECH, INC ... | van Elsas Andrea | Chief Scientific Of ... | Sell | S | 1.31 | 634 | 828 | 520,693 | 521.3 K to 520.7 K (-0.12 %) |
Sep 17 2019 | ADRO | ADURO BIOTECH, INC ... | van Elsas Andrea | Chief Scientific Of ... | Sell | S | 1.31 | 17,959 | 23,451 | 521,327 | 539.3 K to 521.3 K (-3.33 %) |
Sep 17 2019 | ADRO | ADURO BIOTECH, INC ... | Templeman Blaine | Chief Legal Officer | Sell | S | 1.31 | 5,888 | 7,689 | 117,000 | 122.9 K to 117 K (-4.79 %) |
Sep 17 2019 | ADRO | ADURO BIOTECH, INC ... | Templeman Blaine | Chief Legal Officer | Sell | S | 1.31 | 6,990 | 9,128 | 122,888 | 129.9 K to 122.9 K (-5.38 %) |
Jul 15 2019 | ADRO | ADURO BIOTECH, INC ... | WELCH JAMES H | See Remarks | Option Exercise | A | 1.52 | 200,000 | 304,000 | 200,000 | |
Jun 28 2019 | ADRO | ADURO BIOTECH, INC ... | van Elsas Andrea | Chief Scientific Of ... | Grant | A | 0.00 | 275,000 | 0 | 539,286 | 264.3 K to 539.3 K (+104.05 %) |
May 22 2019 | ADRO | ADURO BIOTECH, INC ... | Ferber Celeste | SVP, GC and Secreta ... | Sell | S | 3.21 | 2,000 | 6,413 | 29,436 | 31.4 K to 29.4 K (-6.36 %) |
May 15 2019 | ADRO | ADURO BIOTECH, INC ... | Haghighat Ross | Director | Option Exercise | A | 3.29 | 30,000 | 98,700 | 30,000 | |
May 15 2019 | ADRO | ADURO BIOTECH, INC ... | Greenman William Mariner | Director | Option Exercise | A | 3.29 | 30,000 | 98,700 | 30,000 | |
May 15 2019 | ADRO | ADURO BIOTECH, INC ... | KARBE FRANK | Director | Option Exercise | A | 3.29 | 30,000 | 98,700 | 30,000 | |
May 15 2019 | ADRO | ADURO BIOTECH, INC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 3.29 | 30,000 | 98,700 | 30,000 | |
May 15 2019 | ADRO | ADURO BIOTECH, INC ... | OBrien Stephanie Monaghan | Director | Option Exercise | A | 3.29 | 30,000 | 98,700 | 30,000 | |
May 15 2019 | ADRO | ADURO BIOTECH, INC ... | Mack David Henry | Director | Option Exercise | A | 3.29 | 30,000 | 98,700 | 30,000 | |
May 15 2019 | ADRO | ADURO BIOTECH, INC ... | Nuyten Dimitry SA | Chief Medical Offic ... | Option Exercise | A | 2.98 | 400,000 | 1,192,000 | 400,000 | |
May 03 2019 | ADRO | ADURO BIOTECH, INC ... | Lew Jennifer | Chief Financial Off ... | Option Exercise | M | 1.45 | 12,144 | 17,609 | 121,440 | |
May 03 2019 | ADRO | ADURO BIOTECH, INC ... | Lew Jennifer | Chief Financial Off ... | Option Exercise | M | 1.00 | 2,232 | 2,232 | 22,320 | |
May 03 2019 | ADRO | ADURO BIOTECH, INC ... | Lew Jennifer | Chief Financial Off ... | Option Exercise | M | 0.82 | 4,226 | 3,465 | 42,258 | |
May 03 2019 | ADRO | ADURO BIOTECH, INC ... | Lew Jennifer | Chief Financial Off ... | Sell | S | 4.20 | 12,144 | 51,010 | 135,155 | 147.3 K to 135.2 K (-8.24 %) |
May 03 2019 | ADRO | ADURO BIOTECH, INC ... | Lew Jennifer | Chief Financial Off ... | Buy | M | 1.45 | 12,144 | 17,609 | 147,299 | 135.2 K to 147.3 K (+8.99 %) |
May 03 2019 | ADRO | ADURO BIOTECH, INC ... | Lew Jennifer | Chief Financial Off ... | Sell | S | 4.20 | 2,232 | 9,375 | 135,155 | 137.4 K to 135.2 K (-1.62 %) |
May 03 2019 | ADRO | ADURO BIOTECH, INC ... | Lew Jennifer | Chief Financial Off ... | Buy | M | 1.00 | 2,232 | 2,232 | 137,387 | 135.2 K to 137.4 K (+1.65 %) |
May 03 2019 | ADRO | ADURO BIOTECH, INC ... | Lew Jennifer | Chief Financial Off ... | Sell | S | 4.20 | 4,226 | 17,751 | 135,155 | 139.4 K to 135.2 K (-3.03 %) |
May 03 2019 | ADRO | ADURO BIOTECH, INC ... | Lew Jennifer | Chief Financial Off ... | Buy | M | 0.82 | 4,226 | 3,465 | 139,381 | 135.2 K to 139.4 K (+3.13 %) |
Apr 19 2019 | ADRO | ADURO BIOTECH, INC ... | KARBE FRANK | Director | Option Exercise | A | 3.38 | 60,000 | 202,800 | 60,000 | |
Apr 10 2019 | ADRO | ADURO BIOTECH, INC ... | Lew Jennifer | Chief Financial Off ... | Option Exercise | M | 1.45 | 12,144 | 17,609 | 133,584 | |
Apr 10 2019 | ADRO | ADURO BIOTECH, INC ... | Lew Jennifer | Chief Financial Off ... | Option Exercise | M | 1.00 | 2,232 | 2,232 | 24,552 | |
Apr 10 2019 | ADRO | ADURO BIOTECH, INC ... | Lew Jennifer | Chief Financial Off ... | Option Exercise | M | 0.82 | 4,225 | 3,465 | 46,484 |